4.7 Editorial Material

Prostate Cancer SubtyPINg BiomarKers and Outcome: Is Clarity EmERGing?

期刊

CLINICAL CANCER RESEARCH
卷 20, 期 18, 页码 4733-4736

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-14-0818

关键词

-

类别

资金

  1. NCI NIH HHS [R01 CA183857, R01-CA-183857-01] Funding Source: Medline

向作者/读者索取更多资源

Molecular prostate cancer subtypes have been proposed on the basis of mutually exclusive SPINK1 and ERG overexpression, with conflicting reports on their prognostic ability. Flavin and colleagues report that SPINK1 is neither prognostic nor absolutely mutually exclusive with ERG, raising important questions about prostate cancer molecular subtyping and prognostic biomarker evaluation. (C)2014 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据